MiMedx Group Inc - Company Profile

Powered by

All the sales intelligence you need on MiMedx Group Inc in one solution.

  • Save hours of research time with a comprehensive
    Sales Intelligence Solution.

  • Understand how MiMedx Group Inc fits into your total
    addressable market and Ideal Customer Profile.

  • Gain competitive edge with triggers that tell you
    when and how to engage with MiMedx Group Inc.

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

MiMedx Group Inc (MiMedx) is a company that focuses on the development and distribution of placental biologics. The company provides innovative solutions for wound care, burn treatment and surgical recovery. It offers a range of products such as epifix, epicord, and amniofix, among others which are used in advanced wound and surgical applications. The company’s products are utilized by healthcare professionals, including surgeons and wound care clinicians, to treat patients across various medical fields such as plastic surgery, vascular surgery, and orthopedic surgery. MiMedx is headquartered in Marietta, Georgia, the US.

Gain a 360-degree view of MiMedx Group Inc and make more informed decisions for your business Gain a 360-degree view of MiMedx Group Inc and make more informed decisions for your business Learn more
Headquarters United States of America

Address 1775 W Oak Commons Court, Ne, Marietta, Georgia, 30062

Website mimedx.com

Telephone 1 770 6519100

No of Employees 837

Industry Pharmaceuticals and Healthcare

Ticker Symbol & Exchange MDXG (NASD)

Revenue (2024) $348.9M 8.5% (2024 vs 2023)

EPS XYZ

Net Income (2024) XYZ -27.2% (2024 vs 2023)

Market Cap* $536.2M

Net Profit Margin (2024) XYZ -32.9% (2024 vs 2023)

* As of and is in US$
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Learn more

MiMedx Group Inc premium industry data and analytics

20+

Clinical Trials

Determine MiMedx Group Inc go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

11+

Catalyst Calendar

Proactively evaluate MiMedx Group Inc’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

10+

Lead Sheet

Understand when and why to target accounts of prospective leads, as well as who to reach out to, drawing on intelligence for MiMedx Group Inc’s relevant decision makers and contact details.

1

Regulatory Milestones

Track drug and patent expiries along with geographies impacted.

1

Pipeline Drugs

Identify which of MiMedx Group Inc’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

1

ICT Spend & Tech Priorities

IT Client Prospector provides intelligence on MiMedx Group Inc’s likely spend across technology areas enabling you to understand the digital strategy.

Products and Services

Products
Advanced Wound Solutions
Epifix
Epicord
XYZ
XYZ
XYZ
Understand MiMedx Group Inc portfolio and identify potential areas for collaboration Understand MiMedx Group Inc portfolio and identify potential areas for collaboration Learn more
Image for loader

Competitor Comparison

Key Parameters MiMedx Group Inc Becton Dickinson and Co DePuy Synthes Inc Integra LifeSciences Holdings Corp Organogenesis Holdings Inc
Headquarters United States of America United States of America United States of America United States of America United States of America
City Marietta Franklin Lakes Warsaw Princeton Canton
State/Province Georgia New Jersey Indiana New Jersey Massachusetts
No. of Employees 837 72,000 - 4,396 869
Entity Type Public Public Private Public Public
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Learn more
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Learn more
Executives
Name Position Board Since Age
Kathleen Behrens, Ph.D. Chairman Executive Board - 72
Joseph H. Capper Chief Executive Officer; Director Executive Board - 61
Doug Rice Chief Financial Officer Senior Management - -
Ricci S. Whitlow Chief Operating Officer; Executive Vice President Senior Management - -
William F Hulse Chief Administrative Officer; General Counsel Senior Management 2022 -
Non Dignissim Eros Proin vel Convallis 2026 XY
Non Dignissim Eros Proin vel Convallis 2026 XY
Non Dignissim Eros Proin vel Convallis 2026 XY
Gain insight into MiMedx Group Inc key executives to enhance your sales strategy Gain insight into MiMedx Group Inc key executives to enhance your sales strategy Learn more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Why are you leaving?